Variability in monthly serum bicarbonate measures in hemodialysis patients: a cohort study

被引:8
作者
Patel, Ravi [1 ]
Paredes, William [2 ]
Hall, Charles B. [3 ,4 ]
Nader, Mark A. [5 ]
Sapkota, Deepak [6 ]
Folkert, Vaughn W. [2 ]
Abramowitz, Matthew K. [2 ,3 ]
机构
[1] Thomas Jefferson Univ, Dept Med, Sch Med, Philadelphia, PA 19107 USA
[2] Albert Einstein Coll Med, Div Nephrol, Dept Med, Bronx, NY 10461 USA
[3] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA
[4] Albert Einstein Coll Med, Saul R Korey Dept Neurol, Bronx, NY 10461 USA
[5] Medstar Georgetown Univ, Div Nephrol, Dept Med, Washington, DC USA
[6] Interfaith Med Ctr, Dept Med, Brooklyn, NY USA
基金
美国国家卫生研究院;
关键词
Bicarbonate; Acidosis; Alkalosis; Variability; Hemodialysis; End-stage renal disease; ACID-BASE-BALANCE; METABOLIC-ACIDOSIS; DIALYSIS OUTCOMES; PRACTICE PATTERNS; ASSOCIATION; MORTALITY; CARBONATE; ALBUMIN; PROTEIN; CALCIUM;
D O I
10.1186/s12882-015-0206-2
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Some nephrologists have advocated an individualized approach to the prescription of bicarbonate hemodialysis. However, the utility of monthly serum bicarbonate levels for guiding and evaluating such treatment decisions has not been evaluated. We sought to define the variability of these measurements and to determine factors that are associated with month-to-month variability in pre-dialysis serum bicarbonate. Methods: We examined the monthly variability in serum bicarbonate measurements among 181 hemodialysis patients admitted to a free-standing dialysis unit in the Bronx, NY from 1/1/2008-6/30/2012. All patients were treated with a uniform bicarbonate dialysis prescription (bicarbonate 35 mEq/L, acetate 8 mEq/L). Pre-dialysis serum bicarbonate values were obtained from monthly laboratory reports. Month-to-month variability was defined using a rolling measurement for each time point. Results: Only 34 % of high serum bicarbonate values (>26 mEq/L) remained high in the subsequent month, whereas 60 % converted to normal (22-26 mEq/L). Of all low values (<22 mEq/L), 41 % were normal the following month, while 58 % remained low. Using the mean 3-month bicarbonate, only 29 % of high values remained high in the next 3-month period. In multivariable-adjusted longitudinal models, both low and high serum bicarbonate values were associated with greater variability than were normal values (beta = 0.12 (95 % CI 0.09-0.15) and 0.24 (0.18 to 0.29) respectively). Variability decreased with time, and was significantly associated with age, phosphate binder use, serum creatinine, potassium, and normalized protein catabolic rate. Conclusions: Monthly pre-dialysis serum bicarbonate levels are highly variable. Even if a clinician takes no action, approximately 50 % of bicarbonate values outside a normal range of 22-26 mEq/L will return to normal in the subsequent month. The decision to change the bicarbonate dialysis prescription should not be based on a single bicarbonate value, and even a 3-month mean may be insufficient.
引用
收藏
页数:11
相关论文
共 25 条
[1]   Association of predialysis serum bicarbonate levels with risk of mortality and hospitalization in the Dialysis Outcomes and Practice Patterns Study (DOPPS) [J].
Bommer, J ;
Locatelli, F ;
Satayathum, S ;
Keen, ML ;
Goodkin, DA ;
Saito, A ;
Akiba, T ;
Port, FK ;
Young, EW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 44 (04) :661-671
[2]   The magnitude of metabolic acidosis is dependent on differences in bicarbonate assays [J].
Bray, SH ;
Tung, RL ;
Jones, ER .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (05) :700-703
[3]   Acidosis and nutritional status in hemodialyzed patients [J].
Chauveau, P ;
Fouque, D ;
Combe, C ;
Laville, M ;
Canaud, B ;
Azar, R ;
Cano, N ;
Aparicio, M ;
Leverve, X .
SEMINARS IN DIALYSIS, 2000, 13 (04) :241-246
[4]   Is an Increased Serum Bicarbonate Concentration during Hemodialysis Associated with an Increased Risk of Death? [J].
Chen, Joline L. T. ;
Kalantar-Zadeh, Kamyar .
SEMINARS IN DIALYSIS, 2014, 27 (03) :259-262
[5]   Serum albumin: Relationship to inflammation and nutrition [J].
Don, BR ;
Kaysen, G .
SEMINARS IN DIALYSIS, 2004, 17 (06) :432-437
[6]   K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification - Foreword [J].
Eknoyan, G ;
Levin, NW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) :S14-S266
[7]   A randomized, crossover design study of sevelamer carbonate powder and sevelamer hydrochloride tablets in chronic kidney disease patients on haemodialysis [J].
Fan, Stanley ;
Ross, Calum ;
Mitra, Sandip ;
Kalra, Philip ;
Heaton, Jeremy ;
Hunter, John ;
Plone, Melissa ;
Pritchard, Nick .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (12) :3794-3799
[8]   Lanthanum Carbonate Versus Sevelamer Hydrochloride: Improvement of Metabolic Acidosis and Hyperkalemia in Hemodialysis Patients [J].
Filiopoulos, Vassilis ;
Koutis, Ioannis ;
Trompouki, Sofia ;
Hadjiyannakos, Dimitrios ;
Lazarou, Dimitrios ;
Vlassopoulos, Dimosthenis .
THERAPEUTIC APHERESIS AND DIALYSIS, 2011, 15 (01) :20-27
[9]   A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease [J].
Fouque, D. ;
Kalantar-Zadeh, K. ;
Kopple, J. ;
Cano, N. ;
Chauveau, P. ;
Cuppari, L. ;
Franch, H. ;
Guarnieri, G. ;
Ikizler, T. A. ;
Kaysen, G. ;
Lindholm, B. ;
Massy, Z. ;
Mitch, W. ;
Pineda, E. ;
Stenvinkel, P. ;
Trevinho-Becerra, A. ;
Wanner, C. .
KIDNEY INTERNATIONAL, 2008, 73 (04) :391-398
[10]   Acid-base balance in dialysis patients [J].
Gennari, FJ .
SEMINARS IN DIALYSIS, 2000, 13 (04) :235-239